All In Biotech

Drug Trial Radar · NCT01379989

INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer

Phase III International, Randomized Study of Trabectedin Plus Pegylated Liposomal Doxorubicin (PLD) Versus Carboplatin Plus PLD in Patients With Ovarian Cancer Progressing Within 6-12 Months of Last Platinum

Last checked: Nov 19, 2026Latest source record: Feb 9, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 617 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

617

Actual

Start

Jun 2011

Primary completion

Dec 17, 2020

Study completion Dec 17, 2020

Sponsor

Lead sponsor
Mario Negri Institute for Pharmacological ResearchAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
PharmaMar; Averion International Corporation
First posted
Jun 23, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this multicentric, randomised, Phase III study is to demonstrate superiority, in terms of survival, of trabectedin and Pegylated Liposomal Doxorubicin (PLD) versus carboplatin and PLD in partially-platinum sensitive ovarian cancer patients.

Conditions

  • Ovarian Cancer

Interventions

  • CarboplatinDrug

    Carboplatin AUC 5

  • Pegylated Lipoxomal Doxorubicin (PLD)Drug

    PLD 30 mg/m² i.v.

  • TrabectedinDrug

    trabectedin 1.1 mg/m2 3-hour i.v. infusion on Day 1 every 3 weeks. The use of central venous access is strongly recommended.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall survival (OS)Time frame: This outcome measure will be assess approximately 4.5-5 years after the last patient enrolled

Locations

132 sites in 11 countries. Site status is shown where the registry gives one.

  • Medizinische Universitat Graz

    Graz, Austria

  • Univ. Klinik Frauenheilkunde AKH

    Vienna, Austria

  • Krankenhaus Der Barmherzigen Brueder

    Graz, AT, Austria

  • Univ. Clinic for Gynaecology and Obstetrics - Medical University of Innsbruck

    Innsbruck, AT, Austria

  • AZ Maria Middelares

    Ghent, Belgium

  • UZ Gent

    Ghent, Belgium

  • Imeldaziekenhuis

    Bonheiden, BE, Belgium

  • AZ Klina

    Brasschaat, BE, Belgium

  • Antwerp University Hospital

    Edegem, BE, Belgium

  • UZ Leuven

    Leuven, BE, Belgium

  • CMSE Clinique et Maternité Sainte-Elisabeth

    Namur, BE, Belgium

  • Az Damiaan

    Ostend, BE, Belgium

  • Centrum Voor Oncologie

    Turnhout, BE, Belgium

  • Centre Hospitalier Peltzer La Tourelle (CHPLT)

    Verviers, BE, Belgium

  • CHU Dinant Godinne / UCL Namur

    Yvoir, BE, Belgium

  • Odense University Hospital

    Odense, DK, Denmark

  • Kuopio University Hospital - Kuopio

    Kuopio, Finland

  • Oulu University Hospital

    Oulu, Finland

  • Tampere University Hospital

    Tampere, FI, Finland

  • Staedtisches Klinikum Brandenburg

    Brandenburg an der Havel, Germany

  • Universitatsfrauenklinik Dusseldorf

    Düsseldorf, Germany

  • Kliniken Essen Mitte Evang. Huyssens Stiftung

    Essen, Germany

  • University Medical Center Hamburg

    Hamburg, Germany

  • Universitaetsklinikum Jena

    Jena, Germany

  • Klinikum Leverkusen gGmbH

    Leverkusen, Germany

  • Studienzentrum Onkologie

    Ravensburg, Germany

  • UFK am Klinikum Suedstadt Rostock

    Rostock, Germany

  • Onkologische Schwerpunktpraxis

    Speyer, Germany

  • Charite Universitaetsmedizin

    Berlin, DE, Germany

  • Ev. Waldkrankenhaus Spandau

    Berlin, DE, Germany

  • Praxis Dr. med. Jörg Schilling

    Berlin, DE, Germany

  • Praxisklinik Krebsheilkunde für Frauen

    Berlin, DE, Germany

  • Vivantes Netzwerk für Gesundheit GmbH

    Berlin, DE, Germany

  • University Hospital Dresden

    Dresden, DE, Germany

  • Dr. med. Georg Heinrich Schwerpunktpraxis für Gynäkologische Onkologie

    Fürstenwalde, DE, Germany

  • Kath. Marienkrankenhaus

    Hamburg, DE, Germany

  • Universitäts - Frauenklinik -Tübingen

    Heidelberg, DE, Germany

  • Helios Klinikum Krefeld

    Krefeld, DE, Germany

  • "Universitätsklinikum Schleswig-Holstein

    Lübeck, DE, Germany

  • AOU Materdomini

    Catanzaro, Italy

Showing 40 of 132 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.